Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Palifermin (Kepivance) - Important Safety Information from Biovitrum as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
19/04/2010
Problem Or Issue:
Important Safety Information communication from Biovitrum on the restriction of the therapeutic indication of Palifermin (Kepivance) and consequential changes to product information.
Important Safety Information - Palifermin (Kepivance)
« Back
Date Printed: 03/05/2024